ENTITY

Cerus Corp (CERS US)

1
Analysis
Health CareUnited States
Cerus Corporation develops systems designed to enhance the safety of blood transfusions. The Company's systems inactivate pathogens in blood components and inactivate white blood cells, which are responsible for a variety of adverse transfusion reactions. Cerus' platform technologies prevent viral, bacterial, and cellular replication.
more
Company Presentation21 Feb 2025 05:30
Company Presentation31 Oct 2024 04:30
Company Presentation01 Mar 2023 20:00
Company Presentation25 Mar 2025 20:00
Company Presentation04 Nov 2023 03:00
x